首页> 外文期刊>Arthritis care & research >Development and Initial Validation of a Self-Assessed Lupus Organ Damage Instrument
【24h】

Development and Initial Validation of a Self-Assessed Lupus Organ Damage Instrument

机译:自我评估的狼疮器官损伤仪的研制和初步验证

获取原文
获取原文并翻译 | 示例

摘要

Objective. The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) is a validated instrument for assessing organ damage in systemic lupus erythematosus (SLE). Trained physicians must complete it, thus limiting utility where this is impossible.Methods. We developed and pilot tested a self-assessed organ damage instrument, the Lupus Damage Index Questionnaire (LDIQ), in 37 SLE subjects and 7 physicians. After refinement, 569 English-speaking SLE subjects and 14 rheuma-tologists from 11 international SLE clinics participated in validation. Subjects and physicians completed the instruments separately. We calculated sensitivity, specificity, Spearman's correlations, and agreement using the SDI as the gold standard. Six hundred five SLE participants in the community-based National Data Bank for Rheumatic Diseases (NDB) study completed the LDIQ and we assessed correlations with outcome and disability measures.Results. The mean LDIQ score was 3.3 (range 0-16) and the mean SDI score was 1.5 (range 0-9). The LDIQ had a moderately high correlation with the SDI (Spearman's r = 0.50, P < 0.001). Specificities of individual LDIQ items were >80%, except for neuropathy. Sensitivities were variable and lowest for damage, with <1% prevalence. Agreement between the SDI and LDIQ was > 85% for all but neuropathy, reduced renal function, deforming arthritis, and alopecia. In the NDB, the LDIQ correlated well with the comorbidity index (r = 0.45), the Short Form 36 physical component scale (r = 0.43), the Medical Research Council dyspnea scale (r = 0.40), disability (r = 0.37), and the Systemic Lupus Erythematosus Activity Questionnaire score (r = 0.37).Conclusion. The metric properties of the LDIQ are good compared with the SDI. It has construct validity and correlations with health assessments similar to the SDI. The LDIQ should allow expansion of SLE research. Its ultimate value will be determined in longitudinal studies.
机译:目的。系统性红斑狼疮国际合作诊所/美国风湿病损害指数学院(SDI)是用于评估系统性红斑狼疮(SLE)器官损伤的经过验证的仪器。受过训练的医师必须完成它,从而限制了在不可能的情况下的实用性。我们在37位SLE受试者和7位医师中开发并试点了一种自我评估的器官损伤仪器“狼疮损伤指数调查表(LDIQ)”。经过改进,来自11个国际SLE诊所的569名英语SLE受试者和14名风湿病学家参加了验证。受试者和医师分别完成了仪器。我们使用SDI作为金标准,计算了敏感性,特异性,Spearman相关性和一致性。基于社区的国家风湿病数据库(NDB)研究中的655位SLE参与者完成了LDIQ,我们评估了与结局和残疾措施的相关性。 LDIQ平均得分为3.3(范围0-16),平均SDI得分为1.5(范围0-9)。 LDIQ与SDI具有中等程度的相关性(Spearman的r = 0.50,P <0.001)。除神经病变外,单个LDIQ项目的特异性均> 80%。敏感性是可变的,损害最低,患病率<1%。除了神经病,肾功能下降,关节炎变形和脱发外,所有患者的SDI和LDIQ之间的一致性均> 85%。在NDB中,LDIQ与合并症指数(r = 0.45),简式36身体成分量表(r = 0.43),医学研究理事会呼吸困难量表(r = 0.40),残疾(r = 0.37)以及相关性很好,以及系统性红斑狼疮活动问卷调查得分(r = 0.37)。与SDI相比,LDIQ的度量标准属性很好。它具有类似于SDI的构造效度和与健康评估的相关性。 LDIQ应该允许扩展SLE研究。其最终价值将在纵向研究中确定。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号